{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:39:03Z","timestamp":1791999543311,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007378","name":"Associazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["FISM 2018\/B\/1"],"award-info":[{"award-number":["FISM 2018\/B\/1"]}],"id":[{"id":"10.13039\/100007378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007378","name":"Associazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["R01 AG058501"],"award-info":[{"award-number":["R01 AG058501"]}],"id":[{"id":"10.13039\/100007378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007378","name":"Associazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["R01 NS102633\u201301"],"award-info":[{"award-number":["R01 NS102633\u201301"]}],"id":[{"id":"10.13039\/100007378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["WLC6313040077"],"award-info":[{"award-number":["WLC6313040077"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009797","name":"Barrow Neurological Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009898","name":"Defense Health Agency Consortium","doi-asserted-by":"publisher","award":["MS200066"],"award-info":[{"award-number":["MS200066"]}],"id":[{"id":"10.13039\/100009898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["30 CA091842"],"award-info":[{"award-number":["30 CA091842"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["FG-1907\u201334474"],"award-info":[{"award-number":["FG-1907\u201334474"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["TA-1805\u201331003"],"award-info":[{"award-number":["TA-1805\u201331003"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.msard.2023.104839","type":"journal-article","created":{"date-parts":[[2023,6,18]],"date-time":"2023-06-18T17:33:31Z","timestamp":1687109611000},"page":"104839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients"],"prefix":"10.1016","volume":"76","author":[{"given":"Claudia","family":"Cantoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ghezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Piccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2023.104839_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-63282-3","article-title":"Immune and central nervous system-related miRNAs expression profiling in monocytes of multiple sclerosis patients","volume":"10","author":"Amoruso","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2023.104839_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00915","article-title":"Differentially tolerized mouse antigen presenting cells share a common miRNA signature including enhanced mmu-miR-223-3p expression which is sufficient to imprint a protolerogenic state","volume":"9","author":"Bros","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.msard.2023.104839_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00401-016-1621-6","article-title":"Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"133","author":"Cantoni","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2023.104839_bib0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fcell.2020.00409","article-title":"MicroRNAs: from mechanism to organism","volume":"8","author":"Dexheimer","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.msard.2023.104839_bib0006","doi-asserted-by":"crossref","DOI":"10.1177\/1352458513485654","article-title":"Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis","author":"Fenoglio","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2023.104839_bib0007","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/jnr.20995","article-title":"pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity","volume":"84","author":"Frisullo","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.msard.2023.104839_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor CellsMasters of immunology","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.msard.2023.104839_bib0009","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkh023","article-title":"The microRNA registry","author":"Griffiths-Jones","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.msard.2023.104839_bib0010","article-title":"Analysis of miRNA in normal appearing white matter to identify altered CNS pathways in multiple sclerosis","volume":"1","author":"Guerau-de-Arellano","year":"2015","journal-title":"J. Autoimmune Disord."},{"key":"10.1016\/j.msard.2023.104839_bib0011","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2022.11414","article-title":"Induction of M-MDSCs with IL6\/GM-CSF from adherence monocytes and inhibition by WP1066","volume":"24","author":"Hu","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.msard.2023.104839_bib0012","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/imcb.12042","article-title":"Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis","volume":"96","author":"Iacobaeus","year":"2018","journal-title":"Immunol. Cell Biol."},{"issue":"12","key":"10.1016\/j.msard.2023.104839_bib0013","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41590-018-0237-5","article-title":"Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity","volume":"19","author":"Knier","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.msard.2023.104839_bib0014","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","article-title":"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells","volume":"185","author":"Lechner","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2023.104839_bib0015","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1681\/ASN.2014050468","article-title":"Role of myeloid-derived suppressor cells in glucocorticoid-mediated amelioration of FSGS","volume":"26","author":"Li","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.msard.2023.104839_bib0016","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1189\/jlb.2HI1113-611RR","article-title":"Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide","volume":"96","author":"Liao","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.msard.2023.104839_bib0017","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: a comprehensive guide for design","volume":"15","author":"Lima","year":"2018","journal-title":"RNA Biol."},{"key":"10.1016\/j.msard.2023.104839_bib0018","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/1352458517707069","article-title":"Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count","volume":"24","author":"Longbrake","year":"2018","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2023.104839_bib0019","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1073\/pnas.1913997117","article-title":"STAT3 signaling in myeloid cells promotes pathogenic myelin-specific T cell differentiation and autoimmune demyelination","volume":"117","author":"Lu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.msard.2023.104839_bib0020","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/cmi.2017.5","article-title":"Glucocorticoid receptor promotes the function of myeloid-derived suppressor cells by suppressing HIF1\u03b1-dependent glycolysis","volume":"15","author":"Lu","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.msard.2023.104839_bib0021","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104839_bib0022","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(61)91030-3","article-title":"Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (A.C.T.H.)","volume":"2","author":"Miller","year":"1961","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.msard.2023.104839_bib0023","first-page":"357","article-title":"Myeloid cell distribution and activity in multiple sclerosis","volume":"31","author":"Molin\u00e9-Vel\u00e1zquez","year":"2016","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.msard.2023.104839_bib0024","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2222.2004.01824.x","article-title":"Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes","volume":"34","author":"Mozo","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.msard.2023.104839_bib0025","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.3390\/ijms14034375","article-title":"Expression and genetic analysis of MicroRNAs involved in multiple sclerosis","volume":"14","author":"Ridolfi","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2023.104839_bib0001","unstructured":"STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01904123."},{"key":"10.1016\/j.msard.2023.104839_bib0026","article-title":"Diagnosis of multiple sclerosis: 2017 revisions to the McDonald diagnostic criteria for multiple sclerosis","author":"Thompson","year":"2018","journal-title":"Lancet. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2023.104839_bib0027","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/cgt.2016.19","article-title":"Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases","volume":"23","author":"Thorn","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.msard.2023.104839_bib0028","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1177\/0963689718780194","article-title":"An in Vitro and in Vivo study of the effect of dexamethasone on immunoinhibitory function of induced pluripotent stem cell-derived mesenchymal stem cells","volume":"27","author":"Wang","year":"2018","journal-title":"Cell Transplant."},{"key":"10.1016\/j.msard.2023.104839_bib0029","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1111\/jcmm.15928","article-title":"Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor \u03b2 and S100A8\/9 up-regulation","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.msard.2023.104839_bib0030","article-title":"Corticosteroid adverse effects","author":"Yasir","year":"2021","journal-title":"StatPearls"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823003413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:09:54Z","timestamp":1761901794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823003413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":30,"alternative-id":["S2211034823003413"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104839","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104839"}}